In the developing eye of Drosophila the protein kinase D-Raf controls the specification of the R7 photoreceptor cells. We show that overexpression of wild-type D-Raf inhibits the formation of R7 cells in a dose-dependent manner. Conversely, overexpression of mutant DRaf proteins in which the conserved $388 is replaced by A or by D promotes the formation of supernumerary R7 cells, indicating increased D-Raf activity in vivo. $388 in D-Raf corresponds to $259 in c-Raf, shown to be involved in binding of 14-3-3. We show that analogous substitutions of $259 in c-Raf prevent binding of 14-3-3 ~" to the amino terminus of c-Raf and cause a Ras-independent constitutively increased c-Raf kinase activity. Binding of 14-3-3 ~" to the second binding site at the carboxy terminal Catalytic domain was unaffected by these mutations. These results suggest that the increased kinase activity of mutant D-Raf is caused by the selective loss of 14-3-3 binding to its amino terminus. Therefore, binding of 14-3-3 to the amino terminus of Raf appears to negatively regulate Raf kinase activity in vivo. © 1997 Elsevier Science Ireland Ltd.
Introduction
Signals received by transmembrane receptor tyrosine kinases are transmitted via Ras to a cytoplasmic kinase cascade headed by the serine/threonine kinase Raf (Moelling et al., 1984; Schlessinger, 1993; Avruch et al., 1994; Daum et al., 1994; Dominguez and Hafen, 1996) . Activated Raf binds and activates MEK (MAPK-ERK-kinase) which in turn stimulates ERK (extracellular-signal regulated kinase), a member of the MAP kinase family (Dent et al., 1992; Howe et al., 1992; Moodie et al., 1993; Blumer and Johnson, 1994) .
The Ras/Raf/MEK/ERK cascade mediates the phosphorylation of diverse target proteins which lead to a change in gene expression and thereby induce either cell proliferation * Corresponding author. Tel.: +41 1 2574871; fax: +41 1 3613185; e-mail: hafen@ zool.unizh.ch or differentiation across a broad phylogenetic spectrum of organisms (Marshall, 1994; Dickson, 1995; Radziwill et al., 1995; Seger and Krebs, 1995) .
Mechanisms that regulate the activity of Raf are still not fully understood. While activation of Raf has been analysed intensively, less is known about processes that either prevent or iflactivate Raf kinase activity. Recruitment of Raf to the plasma membrane by GTP-bound Ras is an important step in Raf activation (Dickson et al., 1992; Vojtek et al., 1993; Warne et al., 1993; Zhang et al., 1993; Stokoe et al., 1994) . However, additional membrane-associated factors are required for further activation of the Raf kinase since a membrane-anchored variant of Raf can be further stimulated by EGF treatment in a Ras-independent manner (Leevers et al., 1994) . Moreover, Ras-independent mechanisms or pathways that can regulate Raf activity have also been described (Dent et al., 1995a; Hou et al., 1995; Michaud et al., 1995; Zimmermann et al., 1997) .
Raf is phosphorylated in quiescent cells and its phosphorylation increases at several sites in response to many growth factors which activate Raf (Heidecker et al., 1992; Morrison et al., 1993) . Therefore, it is likely that Raf activity is regulated also by phosphorylation. For example, it has been shown that phosphorylation of Raf by protein kinase C or tyrosine kinases can activate Raf (Fabian et al., 1993; Kolch et al., 1993; Marais et al., 1995; Jelinek et al., 1996) , whereas phosphorylation of the amino terminus of Raf by protein kinase A decreases Raf kinase activity (Cook and McCormick, 1993; Wu et al., 1993; Haefner et al., 1994; Schramm et al., 1994) .
Besides Ras, Raf also associates with other cellular proteins such as the heat shock protein Hsp90 and members of the 14-3-3 protein family which may be involved in regulation and function of Raf (Stancato et al., 1993; Lovric' et al., 1994; Wartmann and Davis, 1994; Aitken, 1995) . Hsp90 is always associated with the carboxy terminal catalytic domain of Raf independent of the subcellular location or activation state of Raf (Stancato et al., 1993) . This association appears to be critical for normal Raf function since mutations in the Drosophila homolog of hsp90, hsp83, have been identified as dominant suppressors of a constitutively active Raf mutant (van der Straten et al., 1997) .
Previously associations of 14-3-3 with Raf and other proteins involved in various signal transduction pathways have been reported (Morrison, 1994; Aitken, 1995) . Members of the 14-3-3 family are ubiquitously expressed abundant proteins which are highly conserved in a broad range of organisms but their function has remained elusive (Aitken et al., 1992) . All 14-3-3 isoforms can form homo-as well as heterodimers that increase the versatility of these proteins .
The role of 14-3-3 proteins in Raf activation is controversial (Morrison, 1995; Aitken, 1996) . While activation of Raf by 14-3-3 in yeast (Freed et al., 1994; Irie et al., 1994) and in the Xenopus system have been reported (Fantl et al., 1994) , Michaud and co-workers performed in vitro studies and found no difference of Raf activity in the absence or presence of associated 14-3-3 protein (Michaud et al., 1995) . Recently, even an inhibition rather than an activation of Raf by 14-3-3 in the absence of activated Ras has been described (Suen et al., 1995) . The interaction between 14-3-3 proteins and Raf appears to be constitutive and does not substantially activate Raf in vitro (Fu et al., 1994) . We have recently shown that binding of activated Ras to Raf directly interferes with the binding of 14-3-3 ~'to the amino terminus but not to the carboxy terminus of c-Raf (Rommel et al., 1996) . In addition, c-Raf derived peptides that prevent binding of Ras or 14-3-3 to c-Raf are able to inhibit the activation of Raf and thereby also of MAP kinases (Muslin et al., 1996; Radziwill et al., 1996) . A mutation of the in vivo phosphorylation site $259 of Raf prevents binding of 14-3-3 (Michaud et al., 1995; Rommel et al., 1996) . Even though the isoform 14-3-3 ~" can be phosphorylated in vitro as well as in vivo, only the unphosphorylated form binds to c-Raf Rommel et al., 1996) . Therefore, it is likely that phosphorylation of Raf and possibly also of the 14-3-3 proteins may be important for the regulation of this interaction. Furthermore, an inactivation of purified Raf by cell membrane-associated protein phosphatases was inhibited by addition of either the recombinant 14-3-3 ~" protein or recombinant hsp90 protein (Dent et al., 1995b) .
The results taken together suggest a role of 14-3-3 in the regulation of Raf activity, however, the molecular mechanisms as well as the biological consequences are not yet completely known.
To clarify the functional significance of the interaction between 14-3-3 and Raf we analysed the effect of mutations in Raf that selectively prevent binding of 14-3-3 in a welldefined in vivo system, the developing eye of Drosophila. In this system, D-Raf activity, in response to the activation of the Sevenless (Sev) receptor tyrosine kinase, controls the recruitment of single R7 cells from groups of equipotent precursors known as the R7 equivalence group (Basler et al., 1991; Greenwald and Rubin, 1992) . We show that overexpression of wild-type D-Raf protein prevents R7 cell development in a dose-dependent manner. Conversely, overexpression of mutant D-Raf proteins in which the conserved residue $388 is replaced by A or by D induces the formation of multiple R7 photoreceptor cells. In parallel, we show that the corresponding mutants in c-Raf prevent binding of 14-3-3 to the amino terminus without affecting the binding to the carboxy terminus and show a Ras-independent constitutively increased c-Raf kinase activity in cell culture. Taken together the results suggest that binding of 14-3-3 to the amino terminus of Raf negatively regulates the Raf kinase activity in vivo.
Results

Overexpression of wild-type D-Raf inhibits R7 cell formation, while exchange of $388 in D-Raf to A or to D induces formation of multiple R7 cells in a dose dependent manner
The Raf-dependent specification of R7 photoreceptor cells in the developing eye of Drosophila is a suitable in vivo model system to analyse the biological effects of mutant Raf proteins on signal transduction. In the developing eye the activation of the Sevenless receptor tyrosine kinase (Sev) controls the recruitment of single R7 cells from groups of equipotent precursors known as the R7 equivalence group. Sev activates via Raf a highly conserved signal transduction pathway. It involves the adapter proteins Drk and Dos, the guanine nucleotide releasing factor Sos, the Rasl protein and the kinases Ksr, Raf, MEK, and Rolled/MAPK (Therrien et al., 1995 (Therrien et al., , 1996 Dominguez and Hafen, 1996; Herbst et al., 1996; Raabe et al., 1996) . The number of extra R7 cells that differentiate in response to Raf activity in each ommatidium is a sensitive measure of the strength of the Raf kinase activity. Increase in Raf kinase activity results in an increasingly irregular arrangement of the ommatidial units and hence a roughening of the normally smooth surface of the eye (Dickson et al., 1992) .
We introduced mutations in the D-raf cDNA sequence that resulted in the substitution of $388 into A or into D residues, respectively. Transgenic flies expressing wild-type D-Raf or either of the two $388 mutants in the R7 equivalence group under the control of the duplicated sev enhancer were generated. The sev enhancer permits high levels of expression selectively in the cells of the R7 equivalence group (Basler et al., 1989) . Several independent transgenic lines were obtained for each of these constructs and the eyes of transgenic flies were analysed.
Control wild-type flies possess smooth eyes with a regular arrangement of ommatidia each containing a single R7 cell (Fig. 1A,E) . Flies expressing the wild-type D-Raf protein have a slightly rough eye because they frequently lack the R7 cell and occasionally also one of the outer photoreceptor cells (Fig. 1B,F) . The 'loss-of-photoreceptor-cell' phenotype is stronger in flies carrying two copies instead of one copy of the D-Raf transgene (data not shown) and is not observed in flies expressing D-Raf under the control of a single sev enhancer (Dickson et al., 1992 ). This indicates that the level of D-Raf expression in a cell is critical and that increased amounts of D-Raf do not lead to the activation but rather to the inactivation of the signal transduction pathway required for R7 cell fate specification.
Contrary to the antagonising effect of the overexpressed wild-type D-Raf, the mutant D-Raf(S388A) expressed at the same level results in the formation of multiple R7 cells in each ommatidium (Fig. 1C,G) . This indicates that a substitution of $388 to A results in an increased activity of D-Raf in the developing eye. The mutant protein D-Raf(S388A) has also been shown to possess increased activity in the specification of the terminal structures in embryonic injection experiments (Baek et al., 1996) . Surprisingly, replacement of $388 by the negative charged residue D also resulted in the formation of multiple R7 photoreceptor cells (Fig. 1D,H ). Assuming that $388 is phosphorylated in vivo we had anticipated that D-Raf(S388A), which cannot be phosphorylated at this site, would behave differently from D-Raf(S388D) where the phosphate group might be mimicked by a carboxyl group. However, we observed no differences in quality or strength of the phenotypes between wild type sev-Raf wt sev-Raf $388A sev.RafS388D 
Exchange ofS259 in c-Raf to A or to D induces Raf kinase activity in a Ras-independent manner
To test whether the mutations in $388 disrupt 14-3-3 binding and result in an increase in Raf kinase activity as expected from our in vivo analyses, we proceeded to characterize the analogous mutants biochemically. Because of the high degree of conservation between D-Raf and c-Raf, especially of the RSXSXP sequence motif within CR2 in the amino terminus ( Fig. 2A,B ) and the well established assays systems for c-Raf activity and 14-3-3 binding to c-Raf, we analysed the analogous mutants in c-Raf in cell culture.
Epitope-tagged c-Raf proteins were transiently expressed in 293 cells and tested by in vitro kinase assays for their ability to phosphorylate purified recombinant kinase-inactive MEK as a Raf-specific substrate (Fig. 3A,B) or by analysing the increase in MAP kinase phosphorylation in transfected cells (Fig. 3C ). Whereas no kinase activity was detectable in immunoprecipitates of kinase-defective cRaf(K375E) mutant protein (Fig. 3A, lane 1) , the mutants c-Raf(S259A) and c-Raf(S259D) showed a 5-6-fold increase in kinase activity compared to the basal activity of wild-type c-Raf (Fig. 3A , compare lanes 2-4). Like in the case of wild-type c-Raf, the activity of the $259 mutant c-Raf proteins can be further stimulated by co-expression of the constitutively activated Ras mutant, Ha-Ras(GI2V) (Fig. 3A, lanes 6-8) . However, the stimulation of the $259 mutants by activated Ras was even two-fold higher compared to the wild-type c-Raf protein (Fig. 3A , lanes 6-8). As a control, the kinase activity of c-Raf(R89L), a mutant defective in Ras binding, was not altered by HaRas(G12V) (Fig. 3A, lanes 5 and 9) . Furthermore, the increased kinase activity of the mutant Raf proteins is comparable to the increase of wild-type c-Raf kinase activity upon stimulation with EGF (Fig. 3B , compare lanes 2, 4 and 6). In contrast to the stimulation of wild-type c-Raf by EGF which is partially blocked by co-expressing dominant negative Ha-Ras(S17N) (Fig. 3B , compare lanes 2 and 3), expression of dominant negative Ras as well as serum starvation had no effect on the increased kinase activity of the $259 mutants of c-Raf (Fig. 3B , lanes 5 and 7). Cell fractionation analyses indicate that the increased kinase activity of wild-type c-Raf stimulated by co-expression of activated Ha-Ras(G12V) is exclusively detected in the membrane fraction. In contrast, the mutants cRaf(S259A) and c-Raf(S259D) showed an increased kinase activity in the cytoplasmic fraction compared to the basal kinase activity of the wild-type c-Raf protein (data not shown). Since translocation of cytoplasmic inactive Raf to the plasma membrane by activated Ras is essential for the activation of Raf, which in turn leads to MAP ldnase activation, it was important to investigate whether these constitutively active Raf mutants also stimulate hyperphosphorylation of MAP kinases despite co-expression of dominant negative Ras or serum starvation. For this purpose, we examined the ability of wild-type c-Raf and the mutant Raf proteins under various conditions to stimulate hyperphosphorylation of the MAP kinase ERK2 (Fig. 3C) . Hyperphosphorylation of ERK2 was not stimulated by overexpression of wild-type c-Raf alone (Fig. 3C , compare lanes 1 and 2), but strongly by either stimulation with EGF or by co-expression of Ha-Ras(G12V) (Fig. 3C,  lanes 3 and 4) . In contrast, expression of c-Raf(S259A) and c-Raf(S259D) resulted in distinct hyperphosphorylation of ERK2 in the absence of EGF and was not abolished by co-expression of dominant negative Ha-Ras(S17N) (Fig.  3C, lanes 5-8) . This indicates that the increased kinase activity of the mutants c-Raf(S259A) and c-Raf(S259D) leads to hyperphosphorylation of MAP kinase despite their location in the cytoplasm (Fig. 3B,C) .
Taken together, the results shown in Fig. 3 indicate that a substitution of $259 into A or into D residues in c-Raf is sufficient to activate Raf and concomitantly MAP kinase in a Ras-independent manner. Hence, the increased kinase activity of $259 mutants of c-Raf parallels the behaviour of the corresponding mutants in D-Raf in the developing eye of Drosophila. (B) Activation of c-Raf by mutation of $259 is independent of the activity of Ras. 293 cells were transfected with plasmids expressing FLAG-tagged c-Raf, cRaf(S259A) and c-Raf(S259D) with ( + ) or without ( -) co-transfection of Ha-ras(S17N). Cells were starved for 6 h prior to cell lysis. In lanes 2 and 3 the cells have been stimulated with EGF (100 ng/ml) for 10 min prior to cell lysis. FLAG-tagged Raf proteins were immunoprecipitated and examined for their kinase activity as described above. Migration of the autophosphorylated Raf proteins and of the phosphorylated GST-MEK(K97R) substrate is indicated. Molecular size markers are shown in kDa. Kinase activity of Raf proteins was quantified by measurement of the amount of 32p incorporated into the GST-MEK(K97R) substrate using a Phosphorlmager (Molecular Dynamics) and is shown relative to the kinase activity of wild-type c-Raf protein (bottom panel).
(C) Effects of c-Raf, c-Raf(S259A) and c-Raf(S259D) on the phosphorylation of the MAP kinase ERK2. 293 cells were transfected with non-coding vector (lane 1), with FLAG-tagged wild-type c-Raf (lanes 2-4), c-Raf(S259A) (lanes 5 and 7) and c-Raf(S259D) (lanes 6 and 8), with or without co-expression of Ha-Ras(G12V) or Ha-RasfN17S), as indicated on the top of each lane. Cells were serum-starved for 6 h before lysis. In one case cells were stimulated with EGF (100 ng/ml) for 10 rain before preparation of the cell lysate (lane 3). Aliquots of the cell lysates were resolved by SDS-PAGE and examined by immunoblotting with an otERK2 antibody. Migration of hypophosphorylated ERK2 (ERK2) and of hyperphosphorylated ERK2 (ERK2-P) is indicated. The somewhat reduced hyperphosphorylation of ERK-2 in the presence of Ha-Ras(S 17N) is not due Ras(S 17N)-mediated suppression of c-Raf(S259A/D) activity since this activity is Ras-independent (B, lanes 5 and 7). It is possible that Ha-Ras(S17N) interferes with the activation of the endogenous c-Raf which may be activated indirectly via a positive feedback loop. We have obtained genetic evidence for the existence of such a positive feedback loop in Drosophila (D.
Brunner and E.H., in preparation). The results shown in (A-C) were reproduced in several independent experiments.
Substitution of $259 selectively abolishes binding of 14-3-3 to the amino terminal regulatory domain without affecting its binding to the carboxy terminal catalytic domain
To test whether the activation of c -R a f by exchange of $259 into A or into D residues in the full-length c -R a f protein is associated with a selective loss of binding of 14-3-3 to the amino terminus, we analysed the binding of the isoform 14-3-3 ~" to c -R a f and mutant proteins (Fig.  4A,B) . For this purpose, full-length c-Raf and the two separated domains, the amino terminus, c-RafNT, and the carboxy terminus, c-RafCT, were expressed together with or without M y c -t a g g e d 14-3-3 ~" (Fig. 4A) . Immunoprecipitates of R a f proteins were tested for co-precipitated 14-3-3 ~" by i m m u n o b l o t analysis. Our results show that 14-3-3 ~" binds to the full-length c-Raf protein as well as to the separately expressed amino terminus and carboxy terminus of c-R a f (Fig. 4A ). This confirms previous findings that there are two independent binding sites for 14-3-3 ~" on c -R a f which may suggest a kind of bivalent binding of dimeric 14-3-3 proteins to full-length c-Raf. The existence of two independent binding sites of 14-3-3 on c -R a f full-length are further supported by the fact that 14-3-3 fails to bind to the isolated amino terminal domain of c -R a f containing a substitution of $259 to A or to D (Fig. 4B, lanes 1-3) , but still binds to the corresponding mutants in the full-length c-Raf protein, because of a second independent binding site on the carboxy terminus of c-Raf (Fig. 4B, lanes 4-6) . This indicates that substitution of $259 selectively abolishes binding of 14-3-3 to the amino terminal domain without affecting its binding to the carboxy terminal catalytic domain (Fig. 4B , compare lanes 4, 5 and 6). It also demonstrates that 14-3-3 can bind to a Raf protein with a constitutively increased kinase activity. The fact that no detectable binding of 14-3-3 ~" was observed to separately expressed c-RafNT protein in which $259 is replaced either by A or by D indicates that $259 is essential for 14-3-3 ~" binding and that it cannot be replaced by another negatively charged amino acid residue (Fig. 4B , compare lanes 1, 2 and 3).
Discussion
The current views on the biological significance of 14-3-3 proteins for the regulation of the activity and function of Raf are controversial (Aitken, 1996) . To examine the role of 14-3-3 proteins on Raf activation in vivo we combined genetic and biochemical analyses of the interaction between D-Raf or c-Raf with 14-3-3. The Raf-dependent specification of R7 photoreceptor cells from equipotent precursors in the developing eye of Drosophila is a suitable in vivo model system to analyse the biological effects of mutant Raf proteins on signal transduction. The number of extra R7 cells that differentiate in response to Raf activity in each ommatidium is a sensitive measure of the strength of the Raf kinase activity.
We have mutated selectively the 14-3-3 binding site in the amino terminal domain of D-Raf as well as c-Raf and tested the effects of these mutations on Raf activity in vivo, in the developing eye, and in cell culture, respectively. The results show that mutations of the conserved serine residue $388 in D-Raf into A or into D residues induce supernumerary R7 cells, indicating a constitutively increased D-Raf kinase activity in vivo, in the developing eye of Drosophila.
The biochemical analyses of the analogous mutants in c-Raf show a Ras-independent activation of c-Raf in cell culture. Furthermore, mutants in the residue $259 of c-Raf, corresponding to $388 in D-Raf, prevent selectively binding of 14-3-3 to the amino terminal regulatory domain without affecting the binding to the carboxy terminal catalytic domain of Raf. The striking correlation between loss of 14-3-3 binding and increase in kinase activity of the $259 mutants of c-Raf and the biological effects of the $388 mutants of D-Raf strongly suggests that preventing 14-3-3 binding to the amino terminal regulatory domain of Raf leads to Raf activation. In wild-type c-Raf displacement of 14-3-3 from the amino terminus is achieved by the interaction with activated Ras and is coupled to the membrane localization where Raf protein becomes fully activated (Rommel et al., 1996) . Hence, binding of 14-3-3 to the amino terminal domain negatively regulates Raf kinase and serves to prevent the activity of cytoplasmic Raf.
Although the constitutively increased kinase activity of the $259 mutants of c-Raf was independent of the activity of Ras, co-expression of constitutively activated Ras was able to further activate the mutants which still have an intact Ras binding domain. This in turn shows that a loss of binding of 14-3-3 to the amino terminal regulatory domain of c-Raf does not prevent activation of c-Raf by activated Ras. Furthermore, we find an increased activity of the $259 mutants of c-Raf in the cytoplasmic fraction, suggesting that membrane localization is not essential for the increased activity of these mutants. Since these mutants stimulate a Ras-independent hyperphosphorylation of ERK2 despite serum starvation or co-expression of dominant negative Ras protein, we conclude that cytosolic active c-Raf proteins are also able to stimulate the MAP kinase cascade.
Recently, 14-3-3 isoforms have been shown to interact with a novel conserved motif that has been found in a number of proteins involved in signal transduction (Aitken, 1996; Muslin et al., 1996) . c-Raf as well as D-Raf have two RSXSXP motives, one within CR2 of the amino terminus and another at the end of the conserved region CR3. In both RSXS*XP motives the residues $259 and $621 in cRaf and the corresponding residues $388 and $743 in D-Raf are two major in vivo phosphorylation sites Baek et al., 1996) . A mutation in $259 leads to an activation of Raf kinase, while a mutation of $621 renders the kinase inactive Michaud et al., 1995; Whitehurst et al., 1995) . We also observed that a mutation of the conserved residue $621 to A or D prevents binding of 14-3-3 to the carboxy terminus of c-Raf (data not shown). The block of 14-3-3-induced germinal vesicle breakdown in Xenopus oocytes by microinjection of phosphopeptides that interfere with the interaction of 14-3-3 and Raf is most likely because the peptides interfere with 14-3-3 binding to both sites in Raf (Muslin et al., 1996; . Thus, binding of 14-3-3 to the catalytic domain of Raf seems to be required for Raf activity.
The two independent binding sites of dimeric 14-3-3 on Raf may allow a bifunctional role of 14-3-3 in regulation of Raf. Here we show that binding of 14-3-3 to the Raf amino terminus negatively regulates the activity of Raf in vivo. While 14-3-3 constitutively binds to the carboxy terminal domain of Raf, it may play a positive role in regulation of Raf kinase activity and function. Therefore, studies of 14-3-3 in regulation of Raf activity using either the wild-type Raf protein or only the truncated carboxy terminal catalytic domain could account for some of the conflicting results (Li et al., 1995; Suen et al., 1995) .
Although phosphorylation has been shown to be important for the association of signal transducers with 14-3-3, it is not clear yet whether the RSXSXP motif has to be phosphorylated for this interaction. We do not observe a difference in quality or strength of the phenotypes between substitutions of $388 to A or to D of the transgenic flies. Assuming that $388 is phosphorylated in vivo, one would anticipate that D-Raf(S388A), which cannot be phosphorylated at this site, would behave differently from DRaf(S388D) where the phosphate group might be mimicked by a carboxyl group. This is not the case. It appears, therefore, that $388 is essential for keeping D-Raf in an inactive conformation. The fact that no detectable binding of 14-3-3 ~-was observed to separately expressed c-RafNT protein in which $259 is replaced either by A or by D indicates that $259 is essential for 14-3-3 ~" binding independent of charge. Furthermore, an amino terminus of c-Raf expressed in E. coli, shown not to be phosphorylated on $259, can still bind to 14-3-3 (Rommel et al., 1996) . Thus, residue $259 within the specific recognition motif RSXS*XP seems to be essential for the association with 14-3-3.
Surprisingly, we observed that overexpression of wildtype tD-Raf inhibits rather than promotes the formation of R7 cells in a dose-dependent manner. The loss of photoreceptor cell phenotype is stronger in flies carrying two copies instead of one copy of the D-Raftransgene (data not shown) and is not observed in flies expressing wild-type D-Raf under the control of a single sev enhancer (Dickson et al., 1992 ). This indicates that the level of D-Raf expression in a cell is critical and that increased amounts of D-Raf do not lead to the activation but rather to the inactivation of the signal transduction pathway required for R7 cell fate specification. The results suggest that Raf-mediated signaling is regulated not only by activation or inactivation effectors but also at the protein level. A possible mechanism could be the titration of a limiting factor essential for Raf activity and function. This could be Ras, Hsp90 and/or 14-3-3, or other yet unknown factors.
Taken together, the data suggest a model of how the binding of 14-3-3 to Raf negatively regulates Raf kinase activity. In unstimulated cells, cytoplasmic Raf is kept in an inactive conformation by 14-3-3 which binds as a dimer to the amino terminal and to the carboxy terminal domain of Raf. A loss of this bivalent binding by preventing 14-3-3 from association to the amino terminal site by mutations in $259 or by the interaction with activated Ras will allow Raf to 'open up' and provide access to the catalytic domain. In the active 'open' conformation 14-3-3 is still bound to the catalytic domain and allows Raf-dependent signalling. This may allow rapid inactivation of Raf by reassociation with the amino terminal domain. 14-3-3 constitutively bound to the carboxy terminus of activated Raf may also, through its now available binding site, recruit other proteins to Raf via 14-3-3 dimerization. Indeed, it has been shown that Cdc25 and c-Bcr bind to Raf via 14-3-3 as an adapter protein (Braselmann and McCormick, 1995; Galaktionov et al., 1995) . In addition, it has been shown that c-Bcr binds more strongly to activated Raf than to its inactive form (Braselmann and McCormick, 1995) . This is consistent with the model proposed here that activation of Raf frees an interaction site of 14-3-3 allowing it to function as an adapter. The recent indication that Raf activation may involve dimer formation (Farrar et al., 1996; Luo et al., 1996) could be accommodated into our model by assuming that binding of dimeric 14-3-3 proteins to two independent binding sites on Raf can mediate intermolecular as well as intramolecular interactions of Raf.
A loss of binding of 14-3-3 on the amino terminal regulatory domain of Raf by mutation of the residue $259 or by binding of activated Ras, both lead to an activation of the Raf kinase. Therefore, we conclude that the binding of 14-3-3 to the amino terminus of Raf negatively regulates Raf kinase activity in vivo. However, 14-3-3 protein bound to the carboxy terminal kinase domain of Raf might be still required for Raf activity and function. It appears that 14-3-3 protein performs at least two separate functions in Raf activation. It may act as a protein chaperone enabling Raf to switch between an active and inactive state, and as an adapter protein between activated Raf and other signaling components. It will be interesting to obtain structural data on the molecular interaction between 14-3-3 and Raf to see how 14-3-3 performs these two functions.
Experimental procedures
Plasmids
Mutations in the full-length D-raf cDNA (DRafG3, 66) resulting in substitution of $388 into A or D, respectively, were introduced by in vitro mutagenesis (Stratagene). Wildtype and mutant D-raf sequences were cloned into a modified PW8 transformation vector (Klemenz et al., 1987) containing two copies of the sev enhancer (Basler et al., 1989) and the hsp70 promoter. Several transgenic lines for each construct were generated as previously described (Basler et al., 1991) . The histological phenotype of different transgenic lines with the same construct is highly consistent. cDNAs of human c-raf, c-raf(S259A), c-raf(S259D), craf(K375E), c-rafCT, c-rafNT, c-rafNT(S259A) and crafNT(S259D) were subcloned in the expression vector pcDNA3 (Invitrogen). All these constructs contain 5" to the human c-raf cDNAs a FLAG-epitope encoding sequence preceded by an optimal Kozak translation initiation sequence. The point mutations leading to substitutions of $259 to A and to D of full-length c-Raf as well as of cRafNT have been generated by in vitro mutagenesis (Stratagene). Plasmids pCis2-Ha-ras(G12V) and pCis2-Haras(S17N) have been published recently (Rommel et al., 1996) . Plasmid pcDNA3-myc-14-3-3 ~" coding for Myc-epitope-tagged 14-3-3 ~" protein were described elsewhere . 70% acetone before they were critical-point dried and coated for examination with a Hitachi S-4000 scanning electron microscope. The preparation of histological sections has been described previously (Basler and Hafen, 1988) .
Cell culture and transfection
Adenovirus 5 E1A/B transformed human embryonic kidney cells (293) were grown in Dulbecco's modified Eagle's medium (DMEM; GIBCO-BRL). The medium was supplemented with 4 mM glutamine, 100 units/ml penicillin, 100 mg/ml streptomycin and 10% foetal calf serum (FCS). 293 cells were transiently transfected using the Lipofectamine Transfection System (GIBCO-BRL) as has been described recently (Rommel et al., 1996) .
Immunoprecipitation and in vitro kinase assay
Immunoprecipitation of the FLAG-epitope-tagged Raf proteins with an anti-FLAG monoclonal antibody (M2,IBI; Kodak) has been described recently (Rommel et al., 1996) . The activity of immunoprecipitated FLAGtagged Raf proteins to phosphorylate recombinant kinaseinactive GST-MEK(K97R) as a Raf-specific substrate was determined by in vitro kinase assays as has been described (Lovric' et al., 1994) . The purification of recombinant kinase inactive GST-MEKl(K97R) protein has been described elsewhere (Huang et al., 1995) .
Immunoblot analysis
Immunoprecipitates of FLAG-tagged Raf proteins were blotted onto nitrocellulose membranes and probed with aFLAG antibody for detection of the FLAG-tagged Raf proteins or with c~Myc (9El0, BAbCO) detecting the Myc-epitope of the Myc-tagged 14-3-3 ~" protein as has been described recently (Martin et al., 1993) . ERK2 proteins were detected with a polyclonal c~ERK2 antibody (UBI). All proteins were visualised with the ECL detection system (Amersham).
Germline transformation
